Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sunday share tips: Destiny Pharma, Invinity Energy Systems

(Sharecast News) - The Financial Mail on Sunday's Midas column spied long-term potential in Destiny Pharma's shares. Focusing on MRSA, other post-operative infections and those chronically ill after taking antibiotics, the company's products had the potential to generate annual sales of over £2bn.

While still in development, some were being tested in laboratories and two had already achieved "extremely promising" results, the tipster said.

Indeed, millions of patients recovering from illnesses and surgery might be helped, with lives even saved and healthcare costs reduced.

Midas also highlighted the track record of Destiny's chief executive officer, Chris Tovey, who played a central role in GW Pharma's transformation from a biotech outfit into a commercial business.

In the process, GW floated on the US Nasdaq at $8.90 a share in 2013 and was bought for $220 eight years later.

Destiny chairman Sir Nigel Rudd was also a safe pair of hands and was "well-known for making money for shareholders".

"Destiny Pharma's drugs are designed to curb the use of antibiotics, help the sick to recover faster and cut healthcare costs.

"The shares have had their ups and downs - and biotech firms are never without risk - but Rudd and Tovey's arrival on the board should inspire confidence. At 50p, Destiny is a long-term buy."

The Sunday Times's Lucy Tobin tipped shares of Invinity Energy Systems to readers, in anticipation of the roll-out yof Mistral, the company's new vanadium flow batteries.

Although they will likely cost twice as much as their lithium equivalents, they will probably last more than four times longer.

Developed together with Siemes, the could also tolerate a large spectrum of temperatures, charge and discharge quite quickly and did not ignite.

Tobin nevertheless pointed out two potential red flags, the fact that Invinity was still turning a loss and its capital position.

Invinity itself had already said as much, telling shareholders it would require more capital in 2024, having already raised £16m during the present year.

Analysts meanwhile expected the company to end 2024 with £20m of debt on its books-

However, the company was expected to turn cashflow positive in 2025.

"It's risky, but the firm's tech is already on sale and impressing blue-chip buyers. Buy."

Share this article

Related Sharecast Articles

Sunday newspaper round-up: Panama Canal, Warhammer, Thames Water
(Sharecast News) - Donald Trump is asking that the Panama Canal be returned to the US unless Panama addresses his criticism of how the waterway is managed. In a post on social media platform Truth Social, Trump described the current arrangement as a complete 'rip-off' which will "immediately stop". He also warned against that the key interoceanic route would not be allowed to fall into the "wrong hands". He also appeared to caution against possible Chinese influence in the canal. - Guardian
Friday newspaper round-up: Aldi, Richard Desmond, Collateral
(Sharecast News) - The grocery industry watchdog is to make a rare intervention in a Yorkshire sprout grower's £3.7m legal case against Aldi over the discount chain's decision to terminate a long-term supply deal. In papers filed at the high court, W Clappison Ltd, which produced sprouts for Aldi's UK arm for 13 years, said its supply agreement was ended in February last year at planting time without reasonable notice so it was unable to find new clients immediately. It said it was forced to cease sprout production and sell off its machinery. - Guardian
Friday newspaper round-up: Aldi, Richard Desmond, Collateral
(Sharecast News) - The grocery industry watchdog is to make a rare intervention in a Yorkshire sprout grower's £3.7m legal case against Aldi over the discount chain's decision to terminate a long-term supply deal. In papers filed at the high court, W Clappison Ltd, which produced sprouts for Aldi's UK arm for 13 years, said its supply agreement was ended in February last year at planting time without reasonable notice so it was unable to find new clients immediately. It said it was forced to cease sprout production and sell off its machinery. - Guardian
Thursday newspaper round-up: Water bills, Brexit, Imperial Brands
(Sharecast News) - Households in England and Wales will see their water bills rise by an average of £31 a year, as suppliers pay to fix leaky pipes and cut pollution. The industry regulator Ofwat said on Thursday it would allow companies to raise average bills will rise by £157 over five years to an average of £597 by 2030 to help pay for investment. - Guardian

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.